Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis

NCT07549269 is registered in ClinicalTrials.gov with Sichuan University as lead sponsor.

NCT NCT07549269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07549269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Nab-Paclitaxel Versus Paclitaxel in Neoadjuvant Immunochemotherapy Therapy for Esophageal Squamous Cell Carcinoma: A Retrospective IPTW-Adjusted Analysis
Lead sponsor
Sichuan University
Phase
Observational
Overall status
Completed
Start date
April 1, 2026
Completion date
August 1, 2026
Enrollment
387 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer